GPCR dimerisation

Life Sciences

Volumn 74, Issue 2-3, 2003, Pages 181-188

  Milligan, Graeme ^a   Ramsay, Douglas ^a   Pascal, Geraldine ^a   Carrillo, Juan J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Dimerisation; G protein coupled receptor; Resonance energy transfer

Indexed keywords

DIMER; EPITOPE; G PROTEIN COUPLED RECEPTOR; PROTEASOME;

AMINO TERMINAL SEQUENCE; BIOLUMINESCENCE; CELL SURFACE; CONFERENCE PAPER; DIMERIZATION; ENERGY TRANSFER; FLUORESCENCE; HETEROLOGOUS EXPRESSION; HUMAN; IMMUNOPRECIPITATION; LYSOSOME; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS;

HOMO;

EID: 0242269463     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.005     Document Type: Conference Paper

References (57)

1. AbdAlla S., Lother H., Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 407(6800):2000;94-98.
2. AbdAlla S., Lother H., Abdel-tawab A.M., Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. Journal of Biological Chemistry. 276(43):2001;39721-39726.
3. Angers S., Salahpour A., Joly E., Hilairet S., Chelsky D., Dennis M., Bouvier M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proceedings of the National Academy of Sciences USA. 97(7):2000;3684-3689.
4. Ayoub M.A., Couturier C., Lucas-Meunier E., Angers S., Fossier P., Bouvier M., Jockers R. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. Journal of Biological Chemistry. 277(24):2002;21522-21528.
5. Babcock G.J., Farzan M., Sodroski J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. Journal of Biological Chemistry. 278(5):2003;3378-3385.
6. Cheng Z.J., Miller L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. Journal of Biological Chemistry. 276(51):2001;48040-48047.
7. Coge F., Guenin S.P., Renouard-Try A., Rique H., Ouvry C., Fabry N., Beauverger P., Nicolas J.P., Galizzi J.P., Boutin J.A., Canet E. Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors. Biochemical Journal. 34(1):1999;231-239.
8. Cornea A., Janovick J.A., Maya-Nunez G., Conn P.M. Gonadotropin releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer. Journal of Biological Chemistry. 276(3):2001;2153- 2158.
9. Cvejic S., Devi L.A. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. Journal of Biological Chemistry. 272(43):1997;26959-26964.
10. Dinger M.C., Bader J.E., Kobor A.D., Kretzschmar A.K., Beck-Sickinger A.G. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. Journal of Biological Chemistry. 278(12):2003;10562-10571.
11. Devi L.A. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends in Pharmacological Sciences. 22(10):2001;532-537.
12. Eidne K.A., Kroeger K.M., Hanyaloglu A.C. Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends in Endocrinology and Metabolism. 13(10):2002;415-421.
13. Filizola M., Weinstein H. Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. Biopolymers. 66(5):2002;317-325.
14. Filizola M., Olmea O., Weinstein H. Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. Protein Engineering. 15(11):2002;881-885.
15. Gama L., Wilt S.G., Breitwieser G.E. Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons. Journal of Biological Chemistry. 276(42):2001;39053-39059.
16. George S.R., O'Dowd B.F., Lee S.P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nature Reviews Drug Discovery. 1(10):2002;808-820.
17. Gines S., Hillion J., Torvinen M., Le Crom S., Casado V., Canela E.I., Rondin S., Lew J.Y., Watson S., Zoli M., Agnati L.F., Verniera P., Lluis C., Ferre S., Fuxe K., Franco R. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proceedings of the National Academy of Sciences USA. 97(15):2000;8606-8611.
18. Guo W., Shi L., Javitch J.A. The fourth transmembrane segment forms the interface of the dopamine d2 receptor homodimer. Journal of Biological Chemistry. 278(7):2003;4385-4388.
19. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., Bouvier M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. Journal of Biological Chemistry. 271(27):1996;16384-16392.
20. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., Hansson A., Watson S., Olah M.E., Mallol J., Canela E.I., Zoli M., Agnati L.F., Ibanez C.F., Lluis C., Franco R., Ferre S., Fuxe K. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. Journal of Biological Chemistry. 277(20):2002;18091- 18097.
21. Issafras H., Angers S., Bulenger S., Blanpain C., Parmentier M., Labbe-Jullie C., Bouvier M., Marullo S. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. Journal of Biological Chemistry. 277(38):2002;34666-34673.
22. Jensen A.A., Hansen J.L., Sheikh S.P., Brauner-Osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). European Journal of Biochemistry. 269(20):2002;5076-5087.
23. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399(6737):1999;697-700.
24. Jordan B.A., Cvejic S., Devi L.A. Opioids and their complicated receptor complexes. Neuropsychopharmacology. 23(4 Suppl.):2000;S5-S18.
25. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., Devi L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proceedings of the National Academy of Sciences USA. 98(1):2001;343-348.
26. Kroeger K.M., Hanyaloglu A.C., Seeber R.M., Miles L.E., Eidne K.A. Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. Journal of Biological Chemistry. 276(16):2001;12736-12743.
27. Latif R., Graves P., Davies T.F. Oligomerization of the human thyrotropin receptor: fluorescent protein-tagged hTSHR reveals post-translational complexes. Journal of Biological Chemistry. 276(48):2001;45217-45224.
28. Latif R., Graves P., Davies T.F. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. Journal of Biological Chemistry. 277(47):2001;45059-45067.
29. Lavoie C., Mercier J.F., Salahpour A., Umapathy D., Breit A., Villeneuve L.R., Zhu W.Z., Xiao R.P., Lakatta E.G., Bouvier M., Hebert T.E. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. Journal of Biological Chemistry. 277(38):2002;35402-35410.
30. Lee S.P., O'Dowd B.F., Ng G.Y., Varghese G., Akil H., Mansour A., Nguyen T., George S.R. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Molecular Pharmacology. 58(1):2000;120-128.
31. Levac B.A., O'Dowd B.F., George S.R. Oligomerization of opioid receptors: generation of novel signaling units. Current Opinion in Pharmacology. 2(1):2002;76-81.
32. McVey M., Ramsay D., Kellett E., Rees S., Wilson S., Pope A.J., Milligan G. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. Journal of Biological Chemistry. 276(17):2001;14092-14099.
33. Marshall F.H. Heterodimerization of G-protein-coupled receptors in the CNS. Current Opinion in Pharmacology. 1(1):2001;40-44.
34. Marshall F.H., Jones K.A., Kaupmann K., Bettler B. GABAB receptors - the first 7TM heterodimers. Trends in Pharmacological Sciences. 20(10):1999;396-399.
35. Mellado M., Vila-Coro A.J., Martinez C., Rodriguez-Frade J.M. Receptor dimerization: a key step in chemokine signaling. Cellular and Molecular Biology. 47(4):2001;575-582.
36. Mercier J.F., Salahpour A., Angers S., Breit A., Bouvier M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. Journal of Biological Chemistry. 277(47):2002;44925-44931.
37. Mohler H., Fritschy J.M. GABAB receptors make it to the top-as dimers. Trends in Pharmacological Sciences. 20(3):1999;87-89.
38. Overton M.C., Blumer K.J. G-protein-coupled receptors function as oligomers in vivo. Current Biology. 10(6):2000;341-344.
39. Overton M.C., Blumer K.J. The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. Journal of Biological Chemistry. 277(44):2002;41463- 41472.
40. Patel R.C., Kumar U., Lamb D.C., Eid J.S., Rocheville M., Grant M., Rani A., Hazlett T., Patel S.C., Gratton E., Patel Y.C. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proceedings of the National Academy of Sciences USA. 99(5):2002;3294- 3299.
41. Patel R.C., Lange D.C., Patel Y.C. Photobleaching fluorescence resonance energy transfer reveals ligand-induced oligomer formation of human somatostatin receptor subtypes. Methods. 27(4):2002;340-348.
42. Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H.J., Hollt V., Schulz S. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). Journal of Biological Chemistry. 276(17):2001;14027-14036.
43. Pfeiffer M., Koch T., Schroder H., Laugsch M., Hollt V., Schulz S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. Journal of Biological Chemistry. 277(22):2002;19762-19772.
44. Ramsay D., Kellett E., McVey M., Rees S., Milligan G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochemical Journal. 365(Pt. 2):2002;429-440.
45. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 288(5463):2000;154-157.
46. Rocheville M., Lange D.C., Kumar U., Sasi R., Patel R.C., Patel Y.C. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. Journal of Biological Chemistry. 275(11):2000;7862-7869.
47. Salahpour A., Angers S., Bouvier M. Functional significance of oligomerization of G-protein-coupled receptors. Trends in Endocrinology and Metabolism. 11(5):2000;163-168.
48. Salim K., Fenton T., Bacha J., Urien-Rodriguez H., Bonnert T., Skynner H.A., Watts E., Kerby J., Heald A., Beer M., McAllister G., Guest P.C. Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. Journal of Biological Chemistry. 277(18):2002;15482- 15485.
49. Snyder S.H., Pasternak G.W. Historical review: Opioid receptors. Trends in Pharmacological Sciences. 24(4):2003;198-205.
50. Terrillon S., Durroux T., Mouillac B., Breit A., Ayoub M.A., Taulan M., Jockers R., Barberis C., Bouvier M. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Molecular Endocrinology. 17(4):2003;677-691.
51. Vila-Coro A.J., Rodriguez-Frade J.M., Martin De Ana A., Moreno-Ortiz M.C., Martinez A.C., Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB Journal. 13(13):1999;1699-1710.
52. White J.H., Wise A., Marshall F.H. Heterodimerization of gamma-aminobutyric acid B receptor subunits as revealed by the yeast two-hybrid system. Methods. 27(4):2002;301-310.
53. Wurch T., Matsumoto A., Pauwels P.J. Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins. FEBS Letters. 507(1):2001;109-113.
54. Xu J., He J., Castleberry A.M., Balasubramanian S., Lau A.G., Hall R.A. Heterodimerization of alpha 2A- and beta 1-Adrenergic Receptors. Journal of Biological Chemistry. 278(12):2003;10770-10777.
55. Yoshioka K., Saitoh O., Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proceedings of the National Academy of Sciences USA. 98(13):2001;7617-7622.
56. Yoshioka K., Saitoh O., Nakata H. Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells. FEBS Letters. 523(1-3):2002;147-151.
57. Zhu C.C., Cook L.B., Hinkle P.M. Dimerization and phosphorylation of thyrotropin-releasing hormone receptors are modulated by agonist stimulation. Journal of Biological Chemistry. 277(31):2002;28228-28237.